BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22722845)

  • 1. A tumour suppressor network relying on the polyamine-hypusine axis.
    Scuoppo C; Miething C; Lindqvist L; Reyes J; Ruse C; Appelmann I; Yoon S; Krasnitz A; Teruya-Feldstein J; Pappin D; Pelletier J; Lowe SW
    Nature; 2012 Jul; 487(7406):244-8. PubMed ID: 22722845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
    Park MH
    J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation.
    Park MH; Wolff EC
    J Biol Chem; 2018 Nov; 293(48):18710-18718. PubMed ID: 30257869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
    Nakanishi S; Cleveland JL
    Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
    Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
    J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal growth and survival mediated by eIF5A, a polyamine-modified translation initiation factor.
    Huang Y; Higginson DS; Hester L; Park MH; Snyder SH
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4194-9. PubMed ID: 17360499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of eIF5A and its hypusine modification in eukaryotes.
    Park MH; Nishimura K; Zanelli CF; Valentini SR
    Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of eukaryotic initiation factor 5A (eIF5A) by specific acetylation of its hypusine residue by spermidine/spermine acetyltransferase 1 (SSAT1).
    Lee SB; Park JH; Folk JE; Deck JA; Pegg AE; Sokabe M; Fraser CS; Park MH
    Biochem J; 2011 Jan; 433(1):205-13. PubMed ID: 20942800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
    Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
    Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
    Wolff EC; Kang KR; Kim YS; Park MH
    Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy.
    Bourourou M; Gouix E; Melis N; Friard J; Heurteaux C; Tauc M; Blondeau N
    J Cereb Blood Flow Metab; 2021 May; 41(5):1080-1090. PubMed ID: 32615885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.
    Maier B; Ogihara T; Trace AP; Tersey SA; Robbins RD; Chakrabarti SK; Nunemaker CS; Stull ND; Taylor CA; Thompson JE; Dondero RS; Lewis EC; Dinarello CA; Nadler JL; Mirmira RG
    J Clin Invest; 2010 Jun; 120(6):2156-70. PubMed ID: 20501948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
    Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
    Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypusinated eukaryotic translation initiation factor 5A in polyamine depletion-induced cytostasis.
    Hyvönen MT; Keinänen TA; Cerrada-Gimenez M; Sinervirta R; Grigorenko N; Khomutov AR; Vepsäläinen J; Alhonen L; Jänne J
    J Biol Chem; 2007 Nov; 282(48):34700-6. PubMed ID: 17901051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
    Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
    Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
    Park MH; Wolff EC; Folk JE
    Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts.
    Chen ZP; Chen KY
    J Cell Physiol; 1997 Mar; 170(3):248-54. PubMed ID: 9066781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms.
    Liu Y; Chen C; Xu Z; Scuoppo C; Rillahan CD; Gao J; Spitzer B; Bosbach B; Kastenhuber ER; Baslan T; Ackermann S; Cheng L; Wang Q; Niu T; Schultz N; Levine RL; Mills AA; Lowe SW
    Nature; 2016 Mar; 531(7595):471-475. PubMed ID: 26982726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation.
    Puleston DJ; Buck MD; Klein Geltink RI; Kyle RL; Caputa G; O'Sullivan D; Cameron AM; Castoldi A; Musa Y; Kabat AM; Zhang Y; Flachsmann LJ; Field CS; Patterson AE; Scherer S; Alfei F; Baixauli F; Austin SK; Kelly B; Matsushita M; Curtis JD; Grzes KM; Villa M; Corrado M; Sanin DE; Qiu J; Pällman N; Paz K; Maccari ME; Blazar BR; Mittler G; Buescher JM; Zehn D; Rospert S; Pearce EJ; Balabanov S; Pearce EL
    Cell Metab; 2019 Aug; 30(2):352-363.e8. PubMed ID: 31130465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.